BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

3.64
Delayed Data
As of Oct 28
 -0.08 / -2.16%
Today’s Change
1.38
Today|||52-Week Range
6.29
+5.36%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues48.3M26.4M25.2M20.7M
 
 
 
 
 
Cost of Goods Sold1.7M2.2M998.0K86.0K
 
 
 
 
 
Depreciation And Amortization180.0K483.0K704.0K770.0K
 
 
 
 
 
 
Operating ExpensesGross Income46.4M23.7M23.5M19.8M
 
 
 
 
 
General Expenses85.8M72.3M80.9M103.0M
 
 
 
 
 
Research And Development72.8M61.0M67.0M84.9M
 
 
 
 
 
Total Operating Expenses87.7M75.0M82.6M103.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-39.4M-48.6M-57.4M-83.2M
 
 
 
 
 
Extraordinary Charge-564.0K-843.0K-821.0K-11.1M
 
 
 
 
 
Interest Expense On Debt5.2M6.5M8.6M10.1M
 
 
 
 
 
Other Expenses1.7M11.0K1.0K943.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-43.0M-55.1M-65.8M-101.3M
 
 
 
 
 
Net Income-43.0M-55.1M-65.8M-101.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS72.9M73.7M84.5M103.2M
 
 
 
 
 
Shares To Calculate EPS Diluted72.9M73.7M84.5M103.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.59-$0.75-$0.78-$0.98
 
 
 
 
 
EPS Diluted-$0.59-$0.75-$0.78-$0.98